Hematopoietic Stem Cell Transplantation Market
Global Hematopoietic Stem Cell Transplantation Market Size, Share & Trends Analysis Report by Transplant Type (Allogenic, and Autologous), by Indication (Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Multiple Myeloma, and Others) and by Application (Bone Marrow Transplant, Peripheral Blood Stem Cells Transplant, and Others) Forecast 2022-2028
The global hematopoietic stem cell transplantation market is anticipated to grow at a significant CAGR during the forecast period. This transplantation is a process that involves the intravenous infusion of allogeneic or autologous stem cells for reestablishing hematopoietic function in patients whose suffering from damaged or defective bone marrow or immune systems. One of the key factors that are boosting the market is the new studies and research on this transplant which has improved the process in the past few years. It solidifies confidence in the healthcare department to boost the market. For instance, in March 2022, as per the research of the Boston University School of Medicine and Massachusetts General Hospital (MGH), the genes have a unique signature expressed by Hematopoietic stem cells (HSCs) capable of undergoing this process. HSCs have the capacity to both differentiate and self-renew into all mature blood cell types, making them promising treatments for various diseases.
Impact of COVID-19 Pandemic on Global Hematopoietic Stem Cell Transplantation Market
The COVID-19 pandemic has impacted the global economy due to a slowdown in the manufacturing of various industries. However, the overall healthcare sector was busy curing the COVID-19 patients and a lot of investments occurred in the healthcare sector, hematopoietic stem cell transplantation (HSCT) market mostly suffered owning to the overly populated COVID-19 patients and high risk of mortality for HSCT recipients. In January 2022, as per the report of the National Library of Medicine, HSCT recipients had high clinical complications and risk of mortality owning to COVID-19. There was a need for ongoing vigilance, masks, social distancing, vaccination, and aggressive management of COVID-19 infection in HSCT recipients. However, as the situation got normal, HSCT demand grew significantly.
Segmental Outlook
The global hematopoietic stem cell transplantation market is segmented based on the transplant type, indication, and application. Based on the transplant type, the market is segmented into allogenic & autologous. Based on the indication, the market is sub-segmented into acute myeloid leukemia, acute lymphoblastic leukemia, hodgkin lymphoma, non-hodgkin lymphoma, multiple myeloma & others. Based on application the market is sub-segmented into bone marrow transplant, peripheral blood stem cells transplant & others. Based on transplant type, the autologous segment is anticipated to propel the growth of the market over the forecast period while, based on application, peripheral blood stem cells transplant is anticipated to grow fastest in the segment during the forecast period.
Global Hematopoietic Stem Cell Transplantation Market Share by Transplant Type, 2021 (%)
The Autologous Transplantation Segment Holds a Major Share in the Global Hematopoietic Stem Cell Transplantation Market
Autologous transplantation holds the major share in the hematopoietic stem cell transplantation market. As per the 2020 report of The Center for International Blood and Marrow Transplant Research (CIBMTR), the annual number of allogeneic transplants recipients surpasses 8,000 a year in the US in 2013 with 9,498 transplants estimated in 2019, up from 9,509 in 2018. The number of autologous transplants recipients in the US had steadily increased since 2000 with 14,270 transplants in 2019. Autologous transplants still represent over 60% of transplant activity in the US. Autologous bone marrow products are collected from the patient and are reinfused after purification methods. The advantages include no Graft-versus-host disease (GVHD).
Regional Outlooks
The global hematopoietic stem cell transplantation market is further segmented based on geography including North America (the US, and Canada), Europe (Italy, Spain, Germany, France, and Others), Asia-Pacific (India, China, Japan, South Korea, and Others), and the Rest of the World (the Middle East &Africa, and Latin America). The North America regional hematopoietic stem cell transplantation market is expected to hold a prominent market share due to the presence of several key market players such as bluebird bio, Inc., Marker Therapeutics, Inc., and others while Europe and Asia-Pacific are anticipated to grow significantly during the forecast period.
Global Hematopoietic Stem Cell Transplantation Market Growth, by Region 2022-2028
The North America Region is Projected to Grow Significantly in the Global Hematopoietic Stem Cell Transplantation Market
The market in the North American region is anticipated to grow significantly throughout the forecast period. It is owing to the high prevalence of leukemia, lymphoma, or myeloma in the region. As per the data from National Cancer Institute, leukemia accounted for 3.2% of all new cancer cases, and 3.9% of all cancer deaths in the US in 2020. For instance, in December 2019, the researchers at the National Eye Institute launched a clinical trial to test the safety of a novel patient-specific stem cell-based therapy to treat geographic atrophy. The advanced dry form of age-related macular degeneration. It is the leading cause of vision loss among people aged 65 years and above.
Market Players Outlook
The major companies serving the global hematopoietic stem cell transplantation market include Lonza Group, Merck & Co. Inc., Pluristem Therapeutics Inc., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers & acquisitions, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in February 2019, Lonza and AllCells entered into a private label partnership for the manufacture and global commercialization of an extensive range of hematopoietic primary cells. This partnership expanded Lonza's broad offering of hematopoietic cell lines and enables cell biologists to easily access a wide selection of high-quality cells to boost their scientific research. Under this agreement, the entire AllCells research portfolio of products beard the Lonza branding and allowed scientists on a global scale to further their research across an array of applications, including drug discovery, toxicity testing, cell therapy, and personalized medicine.
The Report Covers
- Market value data analysis of 2021 and forecast to 2028.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global hematopoietic stem cell transplantation market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
1. Report Summary
- Current Industry Analysis and Growth Potential Outlook
- Impact of COVID-19 on the Global Hematopoietic Stem Cell Transplantation Market
- Recovery Scenario of Global Hematopoietic Stem Cell Transplantation Market
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. BY Region
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
3. Competitive Landscape
3.1. Actinium Pharmaceuticals, Inc.
3.1.1. Overview
3.1.2. Financial Analysis
3.1.3. SWOT Analysis
3.1.4. Recent Developments
3.2. Lonza Group
3.2.1. Overview
3.2.2. Financial Analysis
3.2.3. SWOT Analysis
3.2.4. Recent Developments
3.3. Merck & Co., Inc.
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
3.4. Pluristem Ltd.
3.4.1. Overview
3.4.2. Financial Analysis
3.4.3. SWOT Analysis
3.4.4. Recent Developments
3.5. Sartorius CellGenix GmbH
3.5.1. Overview
3.5.2. Financial Analysis
3.5.3. SWOT Analysis
3.5.4. Recent Developments
3.6. Key Strategy Analysis
3.7. Impact of Covid-19 on Key Players
4. Market Segmentation
4.1. Global Hematopoietic Stem Cell Transplantation Market by Transplant Type
4.1.1. Allogenic
4.1.2. Autologous
4.2. Global Hematopoietic Stem Cell Transplantation Market by Indication
4.2.1. Acute Myeloid Leukemia
4.2.2. Acute Lymphoblastic Leukemia
4.2.3. Hodgkin Lymphoma
4.2.4. Non-Hodgkin Lymphoma
4.2.5. Multiple Myeloma
4.2.6. Others
4.3. Global Hematopoietic Stem Cell Transplantation Market by Application
4.3.1. Bone Marrow Transplant
4.3.2. Peripheral Blood Stem Cells Transplant
4.3.3. Others
5. Regional Analysis
5.1. North America
5.1.1. US
5.1.2. Canada
5.2. Europe
5.2.1. UK
5.2.2. Germany
5.2.3. Italy
5.2.4. Spain
5.2.5. France
5.2.6. Rest of Europe
5.3. Asia-Pacific
5.3.1. China
5.3.2. India
5.3.3. Japan
5.3.4. South Korea
5.3.5. Rest of Asia-Pacific
5.4. Rest of the World
6. Company Profiles
6.1. bluebird bio, Inc.
6.2. Escape Therapeutics, Inc.
6.3. Kiadis Pharma Netherlands B.V.
6.4. Marker Therapeutics, Inc.
6.5. Regen Biopharma, Inc.
6.6. STEMPEUTICS RESEARCH PVT LTD
6.7. Taiga Biotechnologies, Inc.
6.8. Talaris Therapeutics, Inc.
6.9. Takeda pharmaceutical Co. Ltd
1. GLOBAL HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET RESEARCH AND ANALYSIS BY TRANSPLANT TYPE, 2021-2028 ($ MILLION)
2. GLOBAL ALLOGENIC HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
3. GLOBAL AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
4. GLOBAL HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET RESEARCH AND ANALYSIS BY INDICATION, 2021-2028 ($ MILLION)
5. GLOBAL ACUTE MYELOID LEUKEMIA HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
6. GLOBAL ACUTE LYMPHOBLASTIC LEUKEMIA HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
7. GLOBAL HODGKIN LYMPHOMA HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
8. GLOBAL NON- HODGKIN LYMPHOMA HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
9. GLOBAL MULTIPLE MYELOMA HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
10. GLOBAL OTHERS HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
11. GLOBAL HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
12. GLOBAL HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR BONE MARROW TRANSPLANT MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
13. GLOBAL HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR PERIPHERAL BLOOD STEM CELLS TRANSPLANT MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
14. GLOBAL HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR OTHERS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
15. GLOBAL HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2021-2028 ($ MILLION)
16. NORTH AMERICAN HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
17. NORTH AMERICAN HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET RESEARCH AND ANALYSIS BY TRANSPLANT TYPE, 2021-2028 ($ MILLION)
18. NORTH AMERICAN HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET RESEARCH AND ANALYSIS BY INDICATION, 2021-2028 ($ MILLION)
19. NORTH AMERICAN HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
20. EUROPEAN HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
21. EUROPEAN HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET RESEARCH AND ANALYSIS BY TRANSPLANT TYPE, 2021-2028 ($ MILLION)
22. EUROPEAN HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET RESEARCH AND ANALYSIS BY INDICATION, 2021-2028 ($ MILLION)
23. EUROPEAN HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
24. ASIA-PACIFIC HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
25. ASIA-PACIFIC HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET RESEARCH AND ANALYSIS BY TRANSPLANT TYPE, 2021-2028 ($ MILLION)
26. ASIA-PACIFIC HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET RESEARCH AND ANALYSIS BY INDICATION, 2021-2028 ($ MILLION)
27. ASIA-PACIFIC HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
28. REST OF THE WORLD HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
29. REST OF THE WORLD HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET RESEARCH AND ANALYSIS BY TRANSPLANT TYPE, 2021-2028 ($ MILLION)
30. REST OF THE WORLD HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET RESEARCH AND ANALYSIS BY INDICATION, 2021-2028 ($ MILLION)
31. REST OF THE WORLD HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
1. IMPACT OF COVID-19 ON GLOBAL HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET, 2021-2028 ($ MILLION)
2. IMPACT OF COVID-19 ON GLOBAL HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET BY SEGMENT, 2021-2028 ($ MILLION)
3. RECOVERY OF GLOBAL HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET, 2021-2028 (%)
4. GLOBAL HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET SHARE BY TRANSPLANT TYPE, 2021 VS 2028 (%)
5. GLOBAL ALLOGENIC HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
6. GLOBAL AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
7. GLOBAL HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET SHARE BY INDICATION, 2021 VS 2028 (%)
8. GLOBAL ACUTE MYELOID LEUKEMIA HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
9. GLOBAL ACUTE LYMPHOBLASTIC LEUKEMIA HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
10. GLOBAL HODGKIN LYMPHOMA HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
11. GLOBAL NON-HODGKIN LYMPHOMA HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
12. GLOBAL MULTIPLE MYELOMA HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
13. GLOBAL OTHERS HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
14. GLOBAL HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET SHARE BY APPLICATION, 2021 VS 2028 (%)
15. GLOBAL HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR BONE MARROW TRANSPLANT MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
16. GLOBAL HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR PHERIPHERAL BLOOD STEM CELL TRANSPLANT MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
17. GLOBAL HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR OTHERS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
18. GLOBAL HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
19. US HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET SIZE, 2021-2028 ($ MILLION)
20. CANADA HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET SIZE, 2021-2028 ($ MILLION)
21. UK HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET SIZE, 2021-2028 ($ MILLION)
22. FRANCE HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET SIZE, 2021-2028 ($ MILLION)
23. GERMANY HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET SIZE, 2021-2028 ($ MILLION)
24. ITALY HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET SIZE, 2021-2028 ($ MILLION)
25. SPAIN HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET SIZE, 2021-2028 ($ MILLION)
26. REST OF EUROPE HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET SIZE, 2021-2028 ($ MILLION)
27. INDIA HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET SIZE, 2021-2028 ($ MILLION)
28. CHINA HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET SIZE, 2021-2028 ($ MILLION)
29. JAPAN HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET SIZE, 2021-2028 ($ MILLION)
30. SOUTH KOREA HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET SIZE, 2021-2028 ($ MILLION)
31. REST OF ASIA-PACIFIC HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET SIZE, 2021-2028 ($ MILLION)
32. REST OF THE WORLD HEMATOPOIETIC STEM CELL TRANSPLANTATION MARKET SIZE, 2021-2028 ($ MILLION)
